Smegmatis Tuberculosis Drugs | Peer Reviewed Journals
Journal of Clinical Microbiology and Antimicrobials

Journal of Clinical Microbiology and Antimicrobials
Open Access

Smegmatis Tuberculosis Drugs

mycobacterium smegmatis is used for laboratory experiment purposes to aquire knowledge about all the other mycobacterium species. Treatment of TB requires multi-drug therapy comprising; an initial intensive phase of rifampicin, isoniazid, pyrazinamide, and ethambutol daily for two months and a continuation phase of rifampicin and isoniazid for a further 4 months, either daily or 3 times a week. Scholarly open access journals have emerged as an alternative to traditional subscription journals. Open access scholarly journals are available online to the reader without financial, legal, or technical barriers. Scholarly open access journals are journals which are respected for the extensive research and information they provide about the point. The research often possesses refereed meaning that it is reviewed by other scientists who are knowledgeable about the theme of the article. Apart from providing a free access to articles to everyone, it also extends support to other scholarly journals in the peer-review process.

Relevant Topics in Immunology & Microbiology

Top globaltechsummit